198 related articles for article (PubMed ID: 33148998)
1. Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study.
Roth AM; Tran NK; Felsher M; Gadegbeku AB; Piecara B; Fox R; Krakower DS; Bellamy SL; Amico KR; Benitez JA; Van Der Pol B
J Acquir Immune Defic Syndr; 2021 Mar; 86(3):e61-e70. PubMed ID: 33148998
[TBL] [Abstract][Full Text] [Related]
2. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.
Walters SM; Reilly KH; Neaigus A; Braunstein S
Harm Reduct J; 2017 Jun; 14(1):40. PubMed ID: 28662716
[TBL] [Abstract][Full Text] [Related]
3. Applying the Behavioral Model for Vulnerable Populations to Pre-Exposure Prophylaxis Initiation Among Women Who Inject Drugs.
Felsher M; Bellamy S; Piecara B; Van Der Pol B; Laurano R; Roth AM
AIDS Educ Prev; 2020 Dec; 32(6):486-492. PubMed ID: 33779207
[TBL] [Abstract][Full Text] [Related]
4. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.
Roth AM; Aumaier BL; Felsher MA; Welles SL; Martinez-Donate AP; Chavis M; Van Der Pol B
Sex Transm Dis; 2018 Apr; 45(4):217-221. PubMed ID: 29465703
[TBL] [Abstract][Full Text] [Related]
5. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
[TBL] [Abstract][Full Text] [Related]
6. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent W; McFarland W
Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
[TBL] [Abstract][Full Text] [Related]
8. An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs.
Felsher M; Ziegler E; Smith LR; Sherman SG; Amico KR; Fox R; Madden K; Roth AM
Arch Sex Behav; 2020 Aug; 49(6):2205-2212. PubMed ID: 32274742
[TBL] [Abstract][Full Text] [Related]
9. The Influence of PrEP-Related Stigma and Social Support on PrEP-Use Disclosure among Women Who Inject Drugs and Social Network Members.
Felsher M; Dutra K; Monseur B; Roth AM; Latkin C; Falade-Nwulia O
AIDS Behav; 2021 Dec; 25(12):3922-3932. PubMed ID: 34014430
[TBL] [Abstract][Full Text] [Related]
10. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
[TBL] [Abstract][Full Text] [Related]
11. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
[TBL] [Abstract][Full Text] [Related]
13. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
[TBL] [Abstract][Full Text] [Related]
15. "PrEP just isn't my priority": Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA.
Felsher M; Ziegler E; Amico KR; Carrico A; Coleman J; Roth AM
Soc Sci Med; 2021 Apr; 275():113809. PubMed ID: 33735778
[TBL] [Abstract][Full Text] [Related]
16. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
[TBL] [Abstract][Full Text] [Related]
18. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.
Hoornenborg E; Achterbergh RC; van der Loeff MFS; Davidovich U; van der Helm JJ; Hogewoning A; van Duijnhoven YT; Sonder GJ; de Vries HJ; Prins M;
J Int AIDS Soc; 2018 Mar; 21(3):e25105. PubMed ID: 29603900
[TBL] [Abstract][Full Text] [Related]
19. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
[TBL] [Abstract][Full Text] [Related]
20. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
